CRPS Foot Treatment: A Podiatrist’s Guide to Complex Regional Pain Syndrome

What Is CRPS of the Foot?

If you have ever had a foot or ankle injury that healed — but the pain did not — and if that pain feels like burning, feels electric, or makes even a light bed sheet touching your foot unbearable, you may have Complex Regional Pain Syndrome (CRPS). This condition is one of the most disabling and poorly understood pain disorders in medicine, and it is significantly underdiagnosed.

CRPS develops when the nervous system responds to an injury — sometimes a relatively minor one — with a disproportionate and self-perpetuating pain signal. The original injury heals, but the pain pathway becomes pathologically sensitized. CRPS Type I (formerly called Reflex Sympathetic Dystrophy or RSD) occurs without confirmed nerve damage; CRPS Type II (formerly causalgia) involves a specific nerve injury. The foot and ankle are among the most common sites, often triggered by ankle sprains, fractures, foot surgery, or even prolonged immobilization.

In our clinic at Balance Foot & Ankle, we encounter CRPS most often in patients who present with ongoing foot pain 3-6 months after what appears to have been a routine injury or surgical procedure. The classic features — burning quality, skin changes, temperature asymmetry, and allodynia — are often present but not always recognized. Prompt recognition and referral to a pain specialist significantly improves outcomes, as early treatment (within the first year of onset) is substantially more effective than treatment after chronicity is established.

Recognizing CRPS: The Budapest Criteria

Diagnosis uses the Budapest Criteria (the international diagnostic standard since 2003), which requires: continuing pain disproportionate to the inciting event PLUS signs/symptoms from at least three of four categories:

• Sensory: Allodynia (pain from non-painful stimulus like light touch), hyperalgesia (exaggerated response to painful stimulus)
• Vasomotor: Skin temperature asymmetry (more than 1 degree Celsius difference between limbs), skin color changes (red, pale, or mottled/blotchy)
• Sudomotor/Edema: Swelling, sweating asymmetry, changes in sweating
• Motor/Trophic: Reduced range of motion, motor weakness, tremor, dystonia, changes in nail or hair growth, skin atrophy

CRPS does not require all features to be present simultaneously — they fluctuate. A patient may have burning pain and allodynia without obvious skin color changes on one visit and present with mottling and temperature asymmetry on another. This variability is part of why the condition is often missed.

CRPS Foot Treatment: The Multimodal Approach

No single treatment cures CRPS. The evidence-based approach combines multiple modalities simultaneously, targeting the different mechanisms that perpetuate the condition: central sensitization, sympathetic nervous system dysregulation, and behavioral/psychological responses to chronic pain.

Physical Therapy and Graded Motor Imagery

Physical therapy is the cornerstone of CRPS treatment and should be initiated as early as possible. The goal is progressive, graded exposure to the painful limb through movement — a process called desensitization. Starting with non-contact stimuli (exposure to fabrics of varying textures on non-affected areas, then the affected limb), progressing to mirror therapy and graded motor imagery (GMI), and ultimately to functional rehabilitation.

Graded Motor Imagery (GMI) is a three-stage process: limb laterality recognition (identifying left vs. right foot in pictures), imagined movements of the affected limb, and mirror therapy (watching the unaffected foot move in a mirror, which “fools” the brain into processing pain-free movement). Multiple high-quality trials support GMI for CRPS, with meaningful pain reductions in 60-70% of patients. The Recognise app provides standardized laterality training that patients can do at home.

Pharmacologic Management

Gabapentinoids (gabapentin, pregabalin) reduce central sensitization by blocking calcium channels in pain-transmitting neurons. They are often the first-line pharmacologic option. Common starting dose for gabapentin is 300mg three times daily, titrated to effect. SNRIs (duloxetine, venlafaxine) modulate descending pain inhibitory pathways and have evidence in neuropathic pain including CRPS. Low-dose naltrexone (LDN, 1.5-4.5mg nightly) is an emerging option with anti-inflammatory and glial-modulatory effects that several small trials support for CRPS. Bisphosphonates (alendronate, pamidronate) have strong evidence specifically for CRPS — they reduce osteoclast-driven bone turnover that appears to be part of CRPS pathophysiology, with multiple RCTs showing significant pain reduction.

Sympathetic Nerve Blocks

A lumbar sympathetic nerve block interrupts sympathetically maintained pain — the component of CRPS pain driven by abnormal sympathetic nervous system activity. Using fluoroscopy or CT guidance, local anesthetic is injected around the lumbar sympathetic chain (L2-L3 level) to temporarily denervate the sympathetic supply to the foot. If this produces meaningful pain relief (typically within hours), it confirms sympathetically maintained pain and identifies patients likely to benefit from more durable procedures. A series of 3-6 blocks is typically performed; some patients achieve lasting remission, others experience temporary improvement that, when combined with intensive PT, allows functional gains that outlast the block itself.

Spinal Cord Stimulation

For patients with refractory CRPS who have failed 6+ months of conservative management, spinal cord stimulation (SCS) is the most evidence-supported interventional option. Electrodes placed epidurally in the dorsal spinal cord deliver low-level electrical signals that inhibit pain transmission by the gate control mechanism. The landmark Kemler et al. trial (NEJM, 2000) showed SCS significantly superior to PT alone at 6 months and 2 years. Modern Dorsal Root Ganglion (DRG) stimulation targets the L4/L5 ganglia specifically for foot pain, with even better anatomical specificity than conventional SCS.

Ketamine Infusion

Sub-anesthetic intravenous ketamine infusions (0.1-0.5 mg/kg/hour over 4-10 days) target the NMDA receptors that are central to wind-up and central sensitization in CRPS. Multiple case series and some controlled trials report pain reduction of 40-60% in patients with otherwise refractory CRPS. The effects can last months. It is not a first-line option due to the practical requirements (inpatient setting, anesthesia monitoring) and the psychomimetic side effects, but it is a legitimate option for patients exhausting other options.

The Psychological Component

CRPS invariably has psychological dimensions — not because the pain is “in your head,” but because chronic, severe, poorly understood pain reliably produces anxiety, depression, fear-avoidance behavior, and catastrophizing. These psychological responses feed back into the central sensitization cycle, amplifying pain and disability. Addressing these through cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), or pain-focused psychotherapy is not optional — it is part of the standard of care for CRPS and significantly improves functional outcomes when combined with physical and pharmacologic treatment.

The Most Common Mistake in CRPS Management

The most damaging mistake we see is prolonged immobilization of the affected limb. Patients in severe pain naturally protect the foot — they avoid touching it, stop bearing weight on it, and sometimes request casting or immobilization for relief. This is exactly the wrong approach for CRPS. Immobilization accelerates disuse atrophy, reduces peripheral blood flow, worsens central sensitization, and dramatically reduces the chances of functional recovery. The treatment requires moving toward the pain, not away from it — with appropriate professional guidance and graded exposure rather than forcing through severe pain. Finding a pain specialist and PT team experienced in CRPS is essential for this counterintuitive process.

Frequently Asked Questions

Can CRPS in the foot go away completely?

Yes, particularly when diagnosed and treated early (within the first year). Studies show remission rates of 30-50% with appropriate early multimodal treatment. Late-stage or longstanding CRPS (3+ years) has lower remission rates, but meaningful functional improvement is still achievable. The goal of treatment in chronic cases shifts from cure to functional optimization — reducing pain to manageable levels, restoring as much mobility and daily function as possible, and preventing further deterioration.

What triggers CRPS in the foot?

Any injury or procedure to the foot can trigger CRPS in susceptible individuals. The most common triggers are ankle sprains, fractures, foot surgery (including bunionectomy, plantar fascia release, or even minor procedures), and prolonged immobilization. In 5-10% of cases, no identifiable trigger is found. Risk factors that appear to increase susceptibility include psychological stress at the time of injury, female sex, history of migraine or other sensitization conditions, and certain genetic polymorphisms in inflammatory and sympathetic nervous system pathways.

The Bottom Line

CRPS of the foot is a serious neuropathic pain condition that requires early recognition and immediate multimodal treatment. Physical therapy with graded motor imagery, pharmacologic management with gabapentinoids and bisphosphonates, and interventional procedures including sympathetic blocks and spinal cord stimulation form the treatment backbone. The most important factors for a good outcome are early diagnosis, avoiding immobilization, and coordinated care among a podiatrist, pain specialist, and physical therapist. If you have persistent burning foot pain with skin or temperature changes after an injury or surgery, our team at Balance Foot & Ankle in Howell and Bloomfield Hills can evaluate your presentation and coordinate referral to a CRPS-specialized pain management team.